
EtiraRx
Operator of a biopharma research company intended to develop products to overcome tumor heterogeneity. The company advances novel cancer therapeutics, validating molecular drivers of cancers to lead a...
Valuation
$45M
Latest known
Share Price
N/A
Total Raised
$7.2M
Last Round
N/A